Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to treat type 2 diabetes. Novo's drugs Ozempic and Wegovy are household names ...
Viking Therapeutics (NASDAQ: VKTX) soared to center stage earlier this year as a potentially promising player in one of today ...
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...
Hosted on MSN23h
Can't Get Ozempic? There's Concern Over CopycatsModeration and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...
Fifty years ago, 20 of the world's brightest people tried to predict life in 2024. They got an awful lot wrong.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback